Marex Group: Paolo Tonucci sells 16,668 shares
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
Marex Group Ltd (MRX) officer Paolo Tonucci, identified as Chief Strategist and CEO, Capital Markets, sold 16,668 ordinary shares on November 9, 2026. The three reported lots were 3,196 shares at a weighted average $67.8914 per share, 10,760 at $68.7356, and 2,712 at $69.4058. The sales were made under a Rule 10b5-1 plan entered into on October 22, 2025.
Insider Trade Summary 10b5-1
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Sale | Ordinary Shares F1, F2 | 3,196 | $67.8914 | $217K |
| Sale | Ordinary Shares F1, F3 | 10,760 | $68.7356 | $740K |
| Sale | Ordinary Shares F1, F4, F5 | 2,712 | $69.4058 | $188K |
Footnotes (5)
- F1. The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 plan entered into by the Reporting Person on October 22, 2025.
- F2. The price reported in Column 4 is a weighted average price. These shares were sold in transactions at prices ranging from $67.175 to $68.1625, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- F3. The price reported in Column 4 is a weighted average price. These shares were sold in transactions at prices ranging from $68.1775 to $69.1725, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- F4. The price reported in Column 4 is a weighted average price. These shares were sold in transactions at prices ranging from $69.175 to $69.885, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- F5. The number of ordinary shares reported herein includes 220,746 shares underlying unvested deferred bonus plan awards previously granted to the Reporting Person. Each award represents a contingent right to receive one (1) ordinary share of the Issuer upon vesting and settlement of the applicable award.
Key Figures
Key Terms
Rule 10b5-1 plan regulatory
weighted average price financial
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
AI-generated analysis. How Rhea-AI works. Not financial advice.